Table 3.
Importance of hRSV RNA quantification at time of admission to hospital in defining the etiologic role of hRSV in 14 infants with hRSV coinfections or sequential infections during episodes of ARTI
| Pt # | hRSV VL (copies/ml NPA) | hRSV VL kinetics | Assessment of hRSV etiology | Other respiratory viruses detected and potentially responsible |
|---|---|---|---|---|
| 2 | High (>106) | Sharp drop | hRSV-A | AdV |
| 9 | Low (102) | ND | Ruled out | hCoV 229E |
| 25 | Low (102) | ND | Ruled out | AdV, rhino |
| 28 | High (>105) | ND | hRSV-A | Rhino |
| 29 | Medium (104) | Stable | Ruled out | hMPV-A, rhino |
| 30 | High (>105) | Sharp drop | hRSV-A | hMPV-B |
| 31 | Low (102) | Stable | Ruled out | hMPV-A |
| 33 | High (>107) | Sharp drop | hRSV-A | Rhino, influenza B |
| 34 | High (>106) | Sharp drop | hRSV-A | hCoV NL63 |
| 36 | High (>106) | ND | hRSV-A | Rhino |
| 39 | High (>105) | Sharp drop | hRSV-B | hCoV NL63 |
| 58 | High (>107) | Sharp drop | hRSV-A | Rhino |
| 61 | Low (102) | Stable | Ruled out | Parainfluenza 3 |
| 63 | Low (102) | ND | Ruled out | hCoV NL63 |
Pt#, patient number; VL, viral load; ND, not done; AdV, adenoviruses; hCoV, human coronaviruses; hMPV, human metapneumoviruses; rhino, rhinoviruses.